Waltham, MA, United States of America

Mark Sylvester

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Sylvester - Innovator in Antibacterial Compounds

Introduction

Mark Sylvester is an accomplished inventor based in Waltham, MA, USA, recognized for his contributions to the field of antibacterial treatments. His innovative work focuses on developing compounds that provide effective methods for treating bacterial infections, showcasing his commitment to improving healthcare outcomes.

Latest Patents

Mark Sylvester holds a patent titled "Compounds and Methods for Treating Bacterial Infections." This patent includes antibacterial compounds represented by a specific formula, providing a framework for pharmaceutical compositions that incorporate these compounds. The detailed description of the compounds highlights their potential applications in combating challenging bacterial infections.

Career Highlights

Currently, Mark is making significant strides in his role at Entasis Therapeutics, Inc. His research and development efforts contribute to the advancement of new therapeutic strategies, ultimately aiming to serve patients in need of innovative antibacterial solutions. His expertise and focus on research help propel the company's mission in the pharmaceutical landscape.

Collaborations

Throughout his career, Mark has had the pleasure of collaborating with talented professionals, including Janelle Comita-Prevoir and Thomas Francois Durand-Reville. These collaborative efforts enhance the research environment, fostering innovation and leading to groundbreaking discoveries in the field of antibacterial treatment.

Conclusion

Mark Sylvester stands out as a notable inventor with his focus on antibacterial compounds. His patent and ongoing work at Entasis Therapeutics, Inc. demonstrate a dedication to fighting bacterial infections and contribute significantly to the pharmaceutical industry. With the support of his colleagues, he continues to push the boundaries of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…